PT - JOURNAL ARTICLE AU - R.A. Betensky AU - Y. Feng TI - Accounting for incomplete testing in the estimation of epidemic parameters AID - 10.1101/2020.04.08.20058313 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.08.20058313 4099 - http://medrxiv.org/content/early/2020/05/10/2020.04.08.20058313.short 4100 - http://medrxiv.org/content/early/2020/05/10/2020.04.08.20058313.full AB - As the COVID-19 pandemic spreads across the world, it is important to understand its features and responses to public health interventions in real-time. The field of infectious diseases epidemiology has highly advanced modeling strategies that yield relevant estimates. These include the doubling time of the epidemic and various other representations of the numbers of cases identified over time. Crude estimates of these quantities suffer from dependence on the underlying testing strategies within communities. We clarify the functional relationship between testing and the epidemic parameters, and thereby derive sensitivity analyses that explore the range of possible truths under various testing dynamics. We derive the required adjustment to the estimates of interest for New York City. We demonstrate that crude estimates that assume stable testing or complete testing can be biased.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the US National Institutes of Health (R01NS094610) and the US National Science Foundation (DMS-2013789).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available at covidtracking.com and https://github.com/nychealth/coronavirus-data https://covidtracking.com/data